Review of lipid-lowering clinical trials in relation to observational epidemiologic studies
about
Lipidomic analyses in epidemiology.Low density lipoprotein receptor-binding activity in human tissues: quantitative importance of hepatic receptors and evidence for regulation of their expression in vivo.Why are low-density lipoproteins atherogenic?Transgenic mice expressing high plasma concentrations of human apolipoprotein B100 and lipoprotein(a).Assembly of lipoprotein particles containing apolipoprotein-B: structural model for the nascent lipoprotein particleLowering cholesterol, 1988. Rationale, mechanisms, and means.Genetic epidemiology of low-density lipoprotein subclass phenotypes.Beta-blockers, lipoproteins and non-insulin dependent diabetes.Biology of cholesterol, lipoproteins and atherosclerosis.Can adverse effects of dietary fat intake be overestimated as a consequence of dietary fat underreporting?The Helsinki Heart Study: central findings and clinical implications.Selective CETP inhibition and PPARalpha agonism increase HDL cholesterol and reduce LDL cholesterol in human ApoB100/human CETP transgenic mice.Effects of lipids and lipid-lowering therapy on hemostatic factors in patients with myocardial infarction.Tel-Aviv-Heidelberg Three Generation Offspring Study: Genetic and environmental sources of variation and covariation among plasma lipids, lipoproteins, and apoliproteins.Using serum cholesterol to identify high risk and stimulate behavior change: will it work?Comparison between Lovastatin and Cholestyramine in the Treatment of Moderate to Severe Primary Hypercholesterolaemia
P2860
Q30249688-C2C00558-3E83-408D-9499-683A51C0EF28Q33566288-25ECDF79-5F39-4CD9-95A2-3890CDCC3912Q33607440-38448F3A-D6A1-4D64-8C1E-CC25655CB438Q33910842-A6B27534-E4A5-4EE7-B190-73F9A484826BQ34189813-7F8998E9-D277-4DD3-A3BB-528586227731Q35588973-5729CD7A-819C-412A-94D0-13BA1FB2CDDAQ35659632-037BC445-EB70-4570-BCB6-DF7B1F19D2DDQ36722740-827EF761-837C-4304-BD90-4D82BF2A2265Q38695204-C0F73C0B-8519-46AD-84B6-AB96F6936355Q40363158-11E7C1FE-F6C2-42CE-9018-8A393B5B804DQ41190039-DC33BAE0-19B6-428B-B957-ACF33ECBB58EQ43120573-1C298551-0F10-4C7E-84B8-90B837FC121CQ44852501-45ACAE26-0F7E-489D-A543-642CEA1A4AFEQ47803677-D7C7339E-3E63-458F-9209-EFB87B18CF19Q48922228-4FFD28C5-9F3E-4AE6-8ACF-F20A67BB9C05Q58266867-33A84AA1-A7F6-468B-8D8A-ABEA5347C9A9
P2860
Review of lipid-lowering clinical trials in relation to observational epidemiologic studies
description
1987 nî lūn-bûn
@nan
1987 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Review of lipid-lowering clini ...... vational epidemiologic studies
@ast
Review of lipid-lowering clini ...... vational epidemiologic studies
@en
Review of lipid-lowering clini ...... vational epidemiologic studies
@nl
type
label
Review of lipid-lowering clini ...... vational epidemiologic studies
@ast
Review of lipid-lowering clini ...... vational epidemiologic studies
@en
Review of lipid-lowering clini ...... vational epidemiologic studies
@nl
prefLabel
Review of lipid-lowering clini ...... vational epidemiologic studies
@ast
Review of lipid-lowering clini ...... vational epidemiologic studies
@en
Review of lipid-lowering clini ...... vational epidemiologic studies
@nl
P356
P1433
P1476
Review of lipid-lowering clini ...... vational epidemiologic studies
@en
P2093
H A Tyroler
P304
P356
10.1161/01.CIR.76.3.515
P407
P577
1987-09-01T00:00:00Z